Vogt-Koyanagi-Harada Disease Associated with COVID-19 mRNA Vaccine

被引：42
作者：
Koong, Lin Ru [1 ]
Chee, Wai Kitt [1 ]
Toh, Zhi Hong [1 ]
Ng, Xin Le [1 ]
Agrawal, Rupesh [1 ,2 ,3 ,4 ]
Ho, Su Ling [1 ]
机构：
[1] Tan Tock Seng Hosp, Natl Healthcare Grp Eye Inst, Singapore 308433, Singapore
[2] Lee Kong Chian Sch Med, Singapore, Singapore
[3] Singapore Eye Res Inst, Ocular Infect & AntiMicrobials, Singapore, Singapore
[4] Duke NUS Med Sch, Acad & Clin Programme, Ophthalmol & Visual Sci, Singapore, Singapore
来源：
OCULAR IMMUNOLOGY AND INFLAMMATION | 2021年 / 29卷 / 06期
关键词：
COVID-19; vaccine; VKH disease; PfizerBioNtech; vaccine side effects; exudative retinal detachment;
D O I：
10.1080/09273948.2021.1974492
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
A 54-year-old Chinese male with no previous ocular history presented to the ophthalmology department for the bilateral acute painless blurring of vision after receiving the 1st dose of COVID-19 mRNA vaccine (PFIZER-BioNTech/COMIRNATY). Clinical examination and imaging tests were consistent with Vogt-Koyanagi-Hara disease. The patient responded well with a high dose of intravenous methylprednisolone followed by a tapering dose of oral prednisolone.
引用
收藏
页码：1212 / 1215
页数：4
相关论文
共 50 条
  • [21] Intravascular Lymphoma Mimicking a Vogt-Koyanagi-Harada Disease
    Angioi, K.
    Bodaghi, B.
    Kaminsky, P.
    Mokhtari, K.
    Lubetzki, C.
    LeHoang, P.
    [J]. OCULAR IMMUNOLOGY AND INFLAMMATION, 2011, 19 (02) : 132 - 134
  • [22] Clinical Features and Prognosis of Vogt-Koyanagi-Harada Disease
    Tefekli, Esra Guney
    Tutkun, Itknur Tugal
    Urganczoglu, Meri
    [J]. TURK OFTALMOLOJI DERGISI-TURKISH JOURNAL OF OPHTHALMOLOGY, 2005, 35 (02): : 163 - 170
  • [23] Vogt-Koyanagi-Harada disease presenting as optic neuritis
    Rajendram R.
    Evans M.
    Khurana R.N.
    Tsai J.H.
    Rao N.A.
    [J]. International Ophthalmology, 2007, 27 (2-3) : 217 - 220
  • [24] Vogt-Koyanagi-Harada disease following ChAdOx1 nCoV-19 and mRNA-1273 vaccination Maladie de Vogt-Koyanagi-Harada apres une vaccination ChAdOx1 nCoV-19 et mRNA-1273
    Rujkorakarn, P.
    Patamatamkul, S.
    [J]. JOURNAL FRANCAIS D OPHTALMOLOGIE, 2023, 46 (03): : 207 - 210
  • [25] Vogt-Koyanagi-Harada syndrome in children
    Rathinam, SR
    Vijayalakshmi, P
    Namperumalsamy, P
    Nozik, RA
    Cunningham, ET
    [J]. OCULAR IMMUNOLOGY AND INFLAMMATION, 1998, 6 (03) : 155 - 161
  • [26] A COVID-19 Risk Reduction Strategy for the Treatment of Acute Vogt-Koyanagi-Harada Disease Utilizing the Antiviral Potential of Cyclosporine
    Nakayama, Makiko
    Okada, Annabelle A.
    Hayashi, Isami
    Ando, Yoshimasa
    Watanabe, Takayo
    Keino, Hiroshi
    [J]. OCULAR IMMUNOLOGY AND INFLAMMATION, 2023, 31 (02) : 462 - 467
  • [27] Uveitis including Vogt-Koyanagi-Harada syndrome following inactive covid-19 vaccination: a case series
    Shariati, Mehrdad Motamed
    Abrishami, Mojtaba
    Jahani, Shahin
    Bolouki, Ali
    Ansari-Astaneh, Mohamad-Reza
    Hosseini, Seyedeh Maryam
    [J]. JOURNAL OF OPHTHALMIC INFLAMMATION AND INFECTION, 2023, 13 (01)
  • [28] Lymphocytic leukemia presenting as acute Vogt-Koyanagi-Harada disease
    AlZamil, Waseem M.
    [J]. SAUDI JOURNAL OF OPHTHALMOLOGY, 2014, 28 (04) : 319 - 321
  • [29] Vogt-Koyanagi-Harada Syndrome: A Diagnostic Conundrum
    Hussain, Anila
    Khurana, Ritu
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (12)
  • [30] Possible Association between Vogt-Koyanagi-Harada Disease and Coronavirus Disease Vaccine: A Report of Four Cases
    de Queiroz Tavares Ferreira, Felipe
    Araujo, Daniel Cunha
    de Albuquerque, Leonardo Mendonca
    Bianchini, Priscila Monaro
    Holanda, Erick Carneiro
    Pugliesi, Alisson
    [J]. OCULAR IMMUNOLOGY AND INFLAMMATION, 2023, 31 (06) : 1134 - 1140
12345